Prediction of Drug Pathway-based Disease Classes using Multiple Properties of Drugs

被引:10
作者
Chen, Lei [1 ]
Li, Linyang [1 ]
机构
[1] Shanghai Maritime Univ, Coll Informat Engn, Shanghai 201306, Peoples R China
关键词
Drug repositioning; drug classification; pathway; network; mashup; singular value decomposition; multi-label classification; MELANOCYTE-STIMULATING HORMONE; RANDOM-WALK; NETWORK; INTEGRATION; INFORMATION; NIZATIDINE; OLANZAPINE; RAPAMYCIN; PLASMA; LABEL;
D O I
10.2174/0115748936284973240105115444
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Background Drug repositioning now is an important research area in drug discovery as it can accelerate the procedures of discovering novel effects of existing drugs. However, it is challenging to screen out possible effects for given drugs. Designing computational methods are a quick and cheap way to complete this task. Most existing computational methods infer the relationships between drugs and diseases. The pathway-based disease classification reported in KEGG provides us a new way to investigate drug repositioning as such classification can be applied to drugs. A predicted class of a given drug suggests latent diseases it can treat.Objective The purpose of this study is to set up efficient multi-label classifiers to predict the classes of drugs.Methods We adopt three types of drug information to generate drug features, including drug pathway information, label information and drug network. For the first two types, drugs are first encoded into binary vectors, which are further processed by singular value decomposition. For the third type, the network embedding algorithm, Mashup, is employed to yield drug features. Above features are combined and fed into RAndom k-labELsets (RAKEL) to construct multi-label classifiers, where support vector machine is selected as the base classification algorithm.Results The ten-fold cross-validation results show that the classifiers provide high performance with accuracy higher than 0.95 and absolute true higher than 0.92. The case study indicates the novel effects of three drugs, i.e., they may treat new diseases.Conclusion The proposed classifiers have high performance and are superiority to the classifiers with other classic algorithms and drug information. Furthermore, they have the ability to discover new effects of drugs.
引用
收藏
页码:859 / 872
页数:14
相关论文
共 59 条
[1]   Drug repositioning: Identifying and developing new uses for existing drugs [J].
Ashburn, TT ;
Thor, KB .
NATURE REVIEWS DRUG DISCOVERY, 2004, 3 (08) :673-683
[2]   Nizatidine for the treatment of patients with quetiapine-induced weight gain [J].
Atmaca, M ;
Kuloglu, M ;
Tezcan, E ;
Ustundag, B ;
Kilic, N .
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2004, 19 (01) :37-40
[3]   Nizatidine treatment and its relationship with leptin levels in patients with olanzapine-induced weight gain [J].
Atmaca, M ;
Kuloglu, M ;
Tezcan, E ;
Ustundag, B .
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2003, 18 (06) :457-461
[4]  
Blagosklonny Mikhail V, 2023, Oncotarget, V14, P342, DOI [10.18632/oncotarget.28410, 10.18632/oncotarget.28410]
[5]   Random forests [J].
Breiman, L .
MACHINE LEARNING, 2001, 45 (01) :5-32
[6]   Inferring drug-disease associations by a deep analysis on drug and disease networks [J].
Chen, Lei ;
Chen, Kaiyu ;
Zhou, Bo .
MATHEMATICAL BIOSCIENCES AND ENGINEERING, 2023, 20 (08) :14136-14157
[7]   Predicting gene phenotype by multi-label multi-class model based on essential functional features [J].
Chen, Lei ;
Li, Zhandong ;
Zeng, Tao ;
Zhang, Yu-Hang ;
Li, Hao ;
Huang, Tao ;
Cai, Yu-Dong .
MOLECULAR GENETICS AND GENOMICS, 2021, 296 (04) :905-918
[8]  
Chen Y., 2023, Brief. Bioinform
[9]   Systematic Evaluation of Drug-Disease Relationships to Identify Leads for Novel Drug Uses [J].
Chiang, A. P. ;
Butte, A. J. .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2009, 86 (05) :507-510
[10]   Compact Integration of Multi-Network Topology for Functional Analysis of Genes [J].
Cho, Hyunghoon ;
Berger, Bonnie ;
Peng, Jian .
CELL SYSTEMS, 2016, 3 (06) :540-+